EUVIMEDEUVIMED entdecken
Crossref

Acoltremon (Tryptyr) for Dry Eye Disease: A Review of the TRPM8 Agonist Mechanism and Clinical Utility

Muhammad Abdul Haseeb Khan, Syed Mujtaba Hussain, Ahmed Javed

International Journal of Multidisciplinary and Medical Research · 22.05.2026 · 1 (1)

DOI: 10.67464/zn4zdr85 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Multidisciplinary and Medical Research, online erschienen am 22.05.2026. Verfasst von Muhammad Abdul Haseeb Khan und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry Eye Disease (DED) is a multifactorial condition characterized by tear film instability, ocular surface inflammation, and neurosensory abnormalities. While the prevalence of DED is rising globally, affecting over 16 million adults in the US alone, treatment options have historically been limited to artificial tears or anti-inflammatory agents with delayed onset of action. Current therapies, such as calcineurin inhibitors and LFA-1 antagonists, effectively target inflammation but often fail to address the neurosensory component of the disease or provide rapid symptomatic relief. The recent FDA approval of Acoltremon (Tryptyr) introduces a first-in-class TRPM8 agonist that specifically targets the eye’s natural cooling sensors to stimulate tear production. This viewpoint analyzes the clinical utility of Acoltremon, arguing that its novel mechanism fills a critical gap in the "symptoms without signs" treatment paradigm and offers a distinct advantage in rapidity of onset compared to existing immunomodulators.

Zitieren

APA

Khan, M. A. H., Hussain, S. M., & Javed, A. (2026). Acoltremon (Tryptyr) for Dry Eye Disease: A Review of the TRPM8 Agonist Mechanism and Clinical Utility. International Journal of Multidisciplinary and Medical Research, 1(1). https://doi.org/10.67464/zn4zdr85

Vancouver

Khan MAH, Hussain SM, Javed A. Acoltremon (Tryptyr) for Dry Eye Disease: A Review of the TRPM8 Agonist Mechanism and Clinical Utility. International Journal of Multidisciplinary and Medical Research. 2026;1(1). doi:10.67464/zn4zdr85

BibTeX
@article{Khan2026,
  author = {Khan, Muhammad Abdul Haseeb and Hussain, Syed Mujtaba and Javed, Ahmed},
  title = {Acoltremon (Tryptyr) for Dry Eye Disease: A Review of the TRPM8 Agonist Mechanism and Clinical Utility},
  journal = {International Journal of Multidisciplinary and Medical Research},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.67464/zn4zdr85}
}
Kostenlos starten →